Pharmaceutical ETFs popped Friday amid news of Pfizer ‘s (PFE) $160 billion takeover of Irish drugmaker Allergan (AGN) — reportedly the biggest tax inversion deal in history and the largest ever in the health sector. It would allow Pfizer, the New York-based pharma giant, to redomicile in Ireland, which has a much lower corporate tax rate.